This trial is enrolling by invitation!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Amyloidosis
and you are
between 18 and 100
years old
1
2
This is a medium phase trial determining
the safety and dosage of the new treatment, as well as its efficacy.
Show me locations

The purpose

The primary aim of this study will be to examine the diagnostic utility of 18-F Florbetapir PET/MR (Positron Emission Tomography/Magnetic Resonance) in imaging patients with pathologically-confirmed systemic amyloidosis involving the peripheral nerves and compare these results to non-amyloid diseased controls.

Provided treatments

  • Other: 18-F Florbetapir PET/MR scan

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03019029. The sponsor of the trial is Mayo Clinic and it is looking for 10 volunteers for the current phase.
Official trial title:
Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis